Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-01-05 @ 7:14 PM
Study NCT ID:
NCT03119467
Status:
TERMINATED
Last Update Posted:
2019-12-27
First Post:
2017-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RP4010-1601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None